GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan, Inc. (AGN) [hlAlert]

Rating:
Outperform
AGN
up 180.87 %

Allergan, Inc. (AGN) upgraded to Outperform by Wells Fargo

Posted on: Tuesday,  Dec 24, 2013  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Allergan, Inc. (NYSE: AGN) on 12/24/2013, when the stock price was $108.94. Since
then, Allergan, Inc. has gained 180.87% as of 11/24/2015's recent price of $305.98.
If you would have followed this Wells Fargo's recommendation on AGN, you would have gained 180.87% of your investment in 700 days.

Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is engaged in discovering, developing and commercializing specialty pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in more than 100 countries globally. In January 2007, the Company completed the acquisition of Groupe Corneal Laboratoires (Corneal). In October 2007, the Company completed the acquisition of Esprit Pharma Holding Company, Inc. (Esprit). In July 2008, the Company acquired the Aczone (dapsone) gel 5% from QLT USA, Inc. (QLT), a wholly owned subsidiary of QLT Inc. The Company operates in two business segments: specialty pharmaceuticals and medical devices.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/24/2013 8:25 AM Buy
None
108.94
as of 8/27/2015
1 Week down  -2.59 %
1 Month up  47.23 %
3 Months up  33.64 %
1 YTD up  181.53 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/25/2013 8:25 AM Hold
None
83.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy